AbbVie : ABBV

All AbbVie Articles

580 Articles

Lee Jackson | Oct 24, 2023 at 7:20 AM EDT

Why Dividend Aristocrats Like AbbVie May Be the Best Contrarian Ideas Now

These seven top Dividend Aristocrats have been out of favor. Yet they are all trading at quite reasonable levels, pay…

Lee Jackson | Oct 2, 2023 at 8:44 AM EDT

Monday’s Top Analyst Upgrades and Downgrades: AbbVie, Adobe, Advance Auto Parts, Anheuser-Busch, Bumble, Fortinet, Nike, Palo Alto Networks and More

Monday's top analyst upgrades and downgrades included AbbVie, Adobe, Advance Auto Parts, Anheuser-Busch InBev, Bumble, Fortinet, Nike and Palo Alto…

Lee Jackson | Sep 11, 2023 at 7:19 AM EDT

Big Institutions Grab ‘Strong Buy’ Dividend Stocks in a Sector Not Totally Driven by AI

Private equity firms and institutions have been buying up top health care stocks like these seven for their strong total…

Lee Jackson | Jul 27, 2023 at 7:16 AM EDT

Top JP Morgan Strategist Says the Worst May Still Be Coming: 7 Big-Dividend Blue Chips to Buy Now

These seven big-dividend stocks offer growth if the market continues higher, but also a degree of safety if the AI-driven…

Paul Ausick | Jul 25, 2023 at 12:14 PM EDT

Earnings Previews: AbbVie, Comcast, Valero Energy

Before U.S. markets open on Thursday, these three firms will be reporting quarterly results.

Lee Jackson | Jun 2, 2023 at 7:18 AM EDT

The Narrow Rally Likely Is Almost Over: 7 ‘Strong Buy’ Safe-Haven Dividend Kings to Buy Now

Any company that has paid rising dividends for 50 years or more is the epitome of safe and dependable. These…

Lee Jackson | May 12, 2023 at 7:07 AM EDT

Recession and Market Sell-Off Likely Coming Soon: 7 Safe Dividend Aristocrats to Buy Now

These seven top Dividend Aristocrats are trading at reasonable levels, pay dependable dividends and, most of all, are solid and…

Paul Ausick | Apr 25, 2023 at 11:04 AM EDT

Earnings Previews: AbbVie, Altria, American Airlines, Merck

Two pharmaceutical giants, one a Dow component, report quarterly results before markets open on Thursday. A major airline and a…

Lee Jackson | Mar 2, 2023 at 8:46 AM EST

Thursday’s Top Analyst Upgrades and Downgrades: AbbVie, Boeing, Coupang, First Solar, Goldman Sachs, Johnson & Johnson, Monster Beverage, Rivian, Workday and More

Thursday's top analyst upgrades and downgrades included AbbVie, AutoZone, Boeing, Coupang, First Solar, Fortinet, Goldman Sachs, Johnson & Johnson, Marqeta,…

Lee Jackson | Feb 24, 2023 at 7:17 AM EST

7 ‘Strong Buy’ 2023 Dividend Aristocrats to Buy Now and Hold Forever in Your IRA

Here are seven top Dividend Aristocrats with among the largest dividends that retirement-focused investors can buy now and hold forever.…

Lee Jackson | Feb 13, 2023 at 8:53 AM EST

Monday’s Top Analyst Upgrades and Downgrades: AbbVie, Affirm, Lyft, Micron Technology, Tapestry, Walmart, Western Digital and More

Monday's top analyst upgrades and downgrades included AbbVie, Affirm, Bloom Energy, FREYR Battery, International Flavors & Fragrances, Interpublic Group of…

Paul Ausick | Feb 7, 2023 at 12:06 PM EST

Earnings Previews: AbbVie, Cameco, Canopy Growth, PepsiCo, Under Armour

Before U.S. markets open on Thursday, AbbVie, Cameco, Canopy Growth, PepsiCo and Under Armour will report quarterly earnings.

Lee Jackson | Dec 13, 2022 at 6:42 AM EST

Rates Head Higher Again This Week: 5 Value Stocks to Buy Now That Come With Big Dividends

After a big fall rally and with interest rates still rising, it makes sense now to look for top value…

Lee Jackson | Oct 7, 2022 at 7:05 AM EDT

7 ‘Strong Buy’ Dividend Kings to Grab Now in Case a Total Market Meltdown Is Coming

Any company that has paid dividends for 50 consecutive years is the epitome of safe and dependable. These seven Dividend…

Lee Jackson | Sep 21, 2022 at 7:16 AM EDT

Stock Market Could Plunge: These 7 Dividend Aristocrats Can Survive the Fall

Given the looming potential for massive downside as interest rates head higher, these seven Dividend Aristocrat stocks in defensive sectors…

1 … 7 8 9 10 11 … 39

AbbVie : ABBV

All AbbVie Articles

Why Dividend Aristocrats Like AbbVie May Be the Best Contrarian Ideas Now

Monday’s Top Analyst Upgrades and Downgrades: AbbVie, Adobe, Advance Auto Parts, Anheuser-Busch, Bumble, Fortinet, Nike, Palo Alto Networks and More

Big Institutions Grab ‘Strong Buy’ Dividend Stocks in a Sector Not Totally Driven by AI

Top JP Morgan Strategist Says the Worst May Still Be Coming: 7 Big-Dividend Blue Chips to Buy Now

Earnings Previews: AbbVie, Comcast, Valero Energy

The Narrow Rally Likely Is Almost Over: 7 ‘Strong Buy’ Safe-Haven Dividend Kings to Buy Now

Recession and Market Sell-Off Likely Coming Soon: 7 Safe Dividend Aristocrats to Buy Now

Earnings Previews: AbbVie, Altria, American Airlines, Merck

Thursday’s Top Analyst Upgrades and Downgrades: AbbVie, Boeing, Coupang, First Solar, Goldman Sachs, Johnson & Johnson, Monster Beverage, Rivian, Workday and More

7 ‘Strong Buy’ 2023 Dividend Aristocrats to Buy Now and Hold Forever in Your IRA

Monday’s Top Analyst Upgrades and Downgrades: AbbVie, Affirm, Lyft, Micron Technology, Tapestry, Walmart, Western Digital and More

Earnings Previews: AbbVie, Cameco, Canopy Growth, PepsiCo, Under Armour

Rates Head Higher Again This Week: 5 Value Stocks to Buy Now That Come With Big Dividends

7 ‘Strong Buy’ Dividend Kings to Grab Now in Case a Total Market Meltdown Is Coming

Stock Market Could Plunge: These 7 Dividend Aristocrats Can Survive the Fall

How a 73-Year-Old’s First RMD Suddenly Pushed Her Effective Tax Rate to 40 Percent

$10,000 in ETHT Became $7,731 in One Day as Ethereum Cracked Below $1,600

The $400,000 Survivor Benefit Decision Every Widow Has Just 12 Months to Make

How a 73-Year-Old's First RMD Suddenly Pushed Her Effective Tax Rate to 40 Percent

The $400,000 Survivor Benefit Decision Every Widow Has Just 12 Months to Make

How a 73-Year-Old’s First RMD Suddenly Pushed Her Effective Tax Rate to 40 Percent

$10,000 in ETHT Became $7,731 in One Day as Ethereum Cracked Below $1,600

AbbVie : ABBV

All AbbVie Articles

Why Dividend Aristocrats Like AbbVie May Be the Best Contrarian Ideas Now

Monday’s Top Analyst Upgrades and Downgrades: AbbVie, Adobe, Advance Auto Parts, Anheuser-Busch, Bumble, Fortinet, Nike, Palo Alto Networks and More

Big Institutions Grab ‘Strong Buy’ Dividend Stocks in a Sector Not Totally Driven by AI

Top JP Morgan Strategist Says the Worst May Still Be Coming: 7 Big-Dividend Blue Chips to Buy Now

Earnings Previews: AbbVie, Comcast, Valero Energy

The Narrow Rally Likely Is Almost Over: 7 ‘Strong Buy’ Safe-Haven Dividend Kings to Buy Now

Recession and Market Sell-Off Likely Coming Soon: 7 Safe Dividend Aristocrats to Buy Now

Earnings Previews: AbbVie, Altria, American Airlines, Merck

Thursday’s Top Analyst Upgrades and Downgrades: AbbVie, Boeing, Coupang, First Solar, Goldman Sachs, Johnson & Johnson, Monster Beverage, Rivian, Workday and More

7 ‘Strong Buy’ 2023 Dividend Aristocrats to Buy Now and Hold Forever in Your IRA

Monday’s Top Analyst Upgrades and Downgrades: AbbVie, Affirm, Lyft, Micron Technology, Tapestry, Walmart, Western Digital and More

Earnings Previews: AbbVie, Cameco, Canopy Growth, PepsiCo, Under Armour

Rates Head Higher Again This Week: 5 Value Stocks to Buy Now That Come With Big Dividends

7 ‘Strong Buy’ Dividend Kings to Grab Now in Case a Total Market Meltdown Is Coming

Stock Market Could Plunge: These 7 Dividend Aristocrats Can Survive the Fall

How a 73-Year-Old’s First RMD Suddenly Pushed Her Effective Tax Rate to 40 Percent

$10,000 in ETHT Became $7,731 in One Day as Ethereum Cracked Below $1,600

The $400,000 Survivor Benefit Decision Every Widow Has Just 12 Months to Make

Featured Reads

How a 73-Year-Old's First RMD Suddenly Pushed Her Effective Tax Rate to 40 Percent

The $400,000 Survivor Benefit Decision Every Widow Has Just 12 Months to Make